Advances in insulin therapy: a review of insulin degludec
King, A.
Journal of Family Practice 61(5 Suppl): S28-S31
2012
ISSN/ISBN: 1533-7294 PMID: 22577639 Document Number: 657328
Document emailed within 1 workday
Related Documents
Mohan, V.; Das, A.K.; Joshi, S.R. 2015: Insulin Degludec/Insulin Aspart: a Novel Co-formulation for Insulin Intensification Journal of the Association of Physicians of India 63(5 Suppl): 6-7Bantwal, G.; Wangnoo, S.K.; Shunmugavelu, M.; Nallaperumal, S.; Harsha, K.P.; Bhattacharyya, A. 2015: Overview of Clinical Trial Program and Applicability of Insulin Degludec/Insulin Aspart in Diabetes Management Journal of the Association of Physicians of India 63(5 Suppl): 21-28
Rausch, R. 2014: Diabetes mellitus type 1 and 2. Flexible therapy with insulin degludec Medizinische Monatsschrift für Pharmazeuten 37(7): 273-274
Hamaguchi, T.; Sadahiro, K.; Satoh, T. 2015: Current concept of insulin therapy intensification, and the role of human regular insulin and rapid-acting insulin analogs in insulin treatment Nihon Rinsho. Japanese Journal of Clinical Medicine 73(3): 447-452
Chatterjee, S.; Majumder, A.; Goyal, G. 2013: Discovery of insulin--from isletin to degludec and beyond Journal of the Indian Medical Association 111(11): 729
Kalra, S. 2013: Newer basal insulin analogues: degludec, detemir, glargine Jpma. Journal of the Pakistan Medical Association 63(11): 1442-1444
Pérez-Comas, A.; Martínez de Prado, M.T. 1983: Advances in insulin therapy Boletin de la Asociacion Medica de Puerto Rico 75(8): 355-357
Kalra, S. 2013: Advances in insulin therapy JPMA. Journal of the Pakistan Medical Association 63(7): 925-927
Heber, D.; Molitch, M.E.; Sperling, M.A. 1977: Low-dose continuous insulin therapy for diabetic ketoacidosis. Prospective comparison with "conventional" insulin therapy Archives of Internal Medicine 137(10): 1377-1380
Matthaei, S.; Hamann, A. 1997: Current insulin therapy. Treatment with new short-acting and retard insulin analogs Fortschritte der Medizin 115(12): 35-6 39
Afanas'eva, S.N. 1982: Insulin therapy and the nature of immunologic reactions to insulin and pancreatic tissue in diabetes mellitus Terapevticheskii Arkhiv 54(10): 30-32
Bringer, J.; Galtier-Dereure, F.; Augustin-Pascalis, I.; Richard, J.L.; Parer-Richard, C.; Mirouze, J.; Jaffiol, C. 1993: Provisional intensive insulin therapy in non-insulin-dependent diabetes resistant to usual treatment Journees Annuelles de Diabetologie de l'Hotel-Dieu 1993: 115-122
Lundershausen, R.; Potthoff, F.; Häuser, C.; Kaiser, M.; Münscher, C. 2006: Human insulin vs. analogs. What is the cost of supplementary insulin therapy? MMW Fortschritte der Medizin 148(45): 42
Klöppel, G.; Freytag, G.; Graesslin, D. 1973: Preparation of monomer insulin components and insulin-like contaminants from crystalline insulin by isoelectric focusing technique Acta Endocrinologica. Supplementum 173: 58
Chang, T.C.; Wang, L.M.; Cheng, C.Y.; Kuo, H.F.; Liu, P.C.; Ho, L.T. 1990: The action of gliclazide on insulin secretion and insulin sensitivity in non-obese non-insulin dependent diabetic patients Zhonghua Yi Xue Za Zhi 46(2): 79-85
Fernández Landó, L.; Massari, F.; Oviedo, A.; Jiang, H. 2012: Starting an insulin regimen with insulin lispro mix 25 versus glargine insulin for type 2 diabetes Medicina 72(3): 235-242
De Meijer, P.H.; Lutterman, J.A. 1990: Subcutaneous injection with an insulin pen. Insulin absorption and plasma concentrations of glucose and free insulin Netherlands Journal of Medicine 36(1-2): 4-12
Hildebrandt, P. 1991: Subcutaneous absorption of insulin in insulin-dependent diabetic patients. Influence of species, physico-chemical properties of insulin and physiological factors Danish Medical Bulletin 38(4): 337-346
Beck-Nielsen, H.; Henriksen, J.E.; Alford, F.; Hother-Nielson, O. 1996: In vivo glucose metabolism, insulin secretion and, insulin action in Europids with non-insulin-dependent diabetes mellitus (NIDDM) and their first-degree relatives Diabetic Medicine: a Journal of the British Diabetic Association 13(9 Suppl 6: S78-S84
Korányi, L.; Tamás, G.; Gerö, L.; Halmos, T.; Baranyai, E.; Büki, B. 1981: Glucagon antibodies in the blood of insulin-treated diabetics (effect of monospecific and monocomponent insulin therapy on antibody level) Orvosi Hetilap 122(23): 1371-1374